We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $37M
1-Year Est. Return 63.54%
This Fund
S&P 500
This Quarter Est. Return
+15.34%
1 Year Est. Return
+63.54%
3 Year Est. Return
+38.32%
5 Year Est. Return
+47.02%
10 Year Est. Return
+2,091.28%
AUM
$338M
AUM Growth
+$65.4M
Cap. Flow
+$76.2M
Cap. Flow %
22.55%
Top 10 Hldgs %
27.92%
Holding
106
New
39
Increased
24
Reduced
12
Closed
28

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$8.7M
2
GSK icon
GSK
GSK
+$7.94M
3
CNC icon
Centene
CNC
+$7.26M
4
EXAS
Exact Sciences
EXAS
+$6.94M
5
SHPG
Shire pic
SHPG
+$6.83M

Top Sells

Rank Stock Value
1
ATHN
Athenahealth, Inc.
ATHN
+$9.99M
2
IEV icon
iShares Europe ETF
IEV
+$7.22M
3
NUVA
NuVasive, Inc.
NUVA
+$7.07M
4
HUM icon
Humana
HUM
+$6.83M
5
AET
Aetna Inc
AET
+$4.84M

Sector Composition

Rank Sector Weight
1 Healthcare 83.79%
2 Miscellaneous 16.21%
3 Financials 0%
4 Industrials 0%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$795B
$11.8M 3.49%
50,000
-37,500
-43% -$8.71M
HOLX
2
DELISTED
Hologic
HOLX
$10.7M 3.18%
252,500
+38,075
+18% +$1.55M
BIO icon
3
Bio-Rad Laboratories Class A
BIO
$10.1B
$10.6M 3.12%
53,000
+22,500
+74% +$4.33M
BAX icon
4
Baxter International
BAX
$12.2B
$9.34M 2.76%
180,000
+30,000
+20% +$1.48M
BCR
5
DELISTED
CR Bard Inc.
BCR
$9.32M 2.76%
37,500
+1,000
+3% +$241K
BSX icon
6
Boston Scientific
BSX
$63.6B
$9.08M 2.68%
365,000
-15,000
-4% -$365K
EVHC
7
DELISTED
Envision Healthcare Holdings Inc
EVHC
$8.59M 2.54%
140,000
-1,644
-1% -$110K
GMED icon
8
Globus Medical
GMED
$10.1B
$8.46M 2.5%
285,646
+85,646
+43% +$2.34M
EXAS
9
DELISTED
Exact Sciences
EXAS
$8.27M 2.44%
+350,000
New +$6.94M
GSK icon
10
GSK
GSK
$101B
$8.25M 2.44%
+156,500
New +$7.94M
ALXN
11
DELISTED
Alexion Pharmaceuticals
ALXN
$8.18M 2.42%
+67,500
New +$8.7M
UNH icon
12
UnitedHealth
UNH
$337B
$7.79M 2.3%
47,500
-15,000
-24% -$2.46M
ABT icon
13
CALL
Abbott
ABT
$177B
$7.77M 2.3%
+175,000
New +$7.57M
CNC icon
14
Centene
CNC
$32.6B
$7.73M 2.29%
+216,982
New +$7.26M
ICUI icon
15
ICU Medical
ICUI
$3.89B
$7.63M 2.26%
50,000
+27,500
+122% +$4.02M
NXTM
16
DELISTED
NxStage Medical Inc.
NXTM
$7.38M 2.18%
275,000
+17,500
+7% +$483K
RVTY icon
17
Revvity
RVTY
$16.3B
$6.94M 2.05%
+119,500
New +$6.52M
AGN
18
DELISTED
Allergan plc
AGN
$6.9M 2.04%
28,875
+22,175
+331% +$5.16M
ABT icon
19
Abbott
ABT
$177B
$6.88M 2.04%
+155,000
New +$6.7M
UHS icon
20
Universal Health Services
UHS
$10.7B
$6.84M 2.02%
+55,000
New +$6.5M
SHPG
21
DELISTED
Shire pic
SHPG
$6.82M 2.02%
+39,125
New +$6.83M
XENT
22
DELISTED
Intersect ENT, Inc
XENT
$6.65M 1.97%
+387,922
New +$5.43M
IVC
23
DELISTED
Invacare Corporation
IVC
$6.25M 1.85%
525,010
+301,571
+135% +$3.62M
FXH icon
24
PUT
First Trust Health Care AlphaDEX Fund
FXH
$1.14B
$6.24M 1.85%
100,000
+40,000
+67% +$2.44M
TFX icon
25
Teleflex
TFX
$5.42B
$5.81M 1.72%
+30,000
New +$5.4M
1
2 3 4 5

Similar funds

MAM
Madryn Asset Management New York $36.9M AUM
GSEP
Golden State Equity Partners South Coast Metro, California $37.1M AUM 20.75% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $37.4M AUM 28.82% 1-Year Est. Return
XA
X Advisors Santa Maria, California $37.6M AUM
YEPI
Yorktown Energy Partners IX New York $36.1M AUM 16.72% 1-Year Est. Return
PEP
Pickering Energy Partners Houston, Texas $36M AUM 0.95% 1-Year Est. Return
CP
Centerbridge Partners New York $38.1M AUM 9.24% 1-Year Est. Return
WTG
West Tower Group Richmond, Virginia $35.6M AUM 53.64% 1-Year Est. Return

Pura Vida Investments's Q1 2017 Portfolio in Review

As of Q1 2017, Pura Vida Investments held 106 positions worth $338M, up 24% from $273M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Pura Vida Investments deployed $76.2M of net new capital in Q1 2017, opening 39 new positions and adding to 24 existing holdings. Its largest new stake was Alexion Pharmaceuticals: 67,500 shares worth $8.18M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 62% a quarter earlier, followed by Miscellaneous and Financials.

On the sell side, the largest reduction was AbbVie, an estimated $4.26M trimmed.

  • Pura Vida Investments's largest Q1 2017 buy was Alexion Pharmaceuticals: 67,500 shares worth $8.18M.
  • Pura Vida Investments added most to Allergan plc in Q1 2017, an estimated $5.16M increase.
  • Pura Vida Investments's biggest Q1 2017 reduction was AbbVie, cutting an estimated $4.26M.
  • Pura Vida Investments fully exited Athenahealth, Inc. in Q1 2017, selling an estimated $9.99M.
  • Pura Vida Investments's ten largest holdings make up 28% of its $338M portfolio in Q1 2017.
  • Pura Vida Investments opened 39 new positions and closed 28 in Q1 2017.
  • Pura Vida Investments's portfolio value rose 24% quarter-over-quarter to $338M.

Based on Pura Vida Investments's 13F filing for Q1 2017, filed 15 May 2017.